-
Recent Posts
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink)
- Timeless Good Advice? (Action for Happiness)
- The Diversionary Value of Music Playlists for Patients With Dementia in Accident and Emergency Settings (Nurses.co.uk / BBC News)
- More on the Possible Role of Neuroinflammation in Frontotemporal Dementia (Bazian / Brain)
Archives
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Sage Bionetworks
Deep and Frequent Phenotyping Study: Dementia Early Detection and Biomarkers Research Programme (MRC / NIHR)
Summary The Deep and Frequent Phenotyping Study will explore improvements in biomarker research and the development of tests to detect Alzheimer’s Disease early on. This research programme will be funded by the National Institute of Health Research (NIHR) and the … Continue reading →
Posted in Alzheimer's Society, Charitable Bodies, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, National, NIHR, Quick Insights, UK, Universal Interest
|
Tagged Alterations in Movement and Walking (“Gait”) Assessments, Alzheimer's Disease: Early Detection by Brain Scan, Alzheimer’s Disease Biomarkers, Aridhia, AstraZeneca / MedImmune, Berry Consultants, Biomarker Assessments in Alzheimer’s Disease, Biomarker Assessments in Alzheimer’s Disease Clinical Trials, Biomarker Assessments in Clinical Trials, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Biomarkers Research Programmes, Blood and Urine Biomarkers, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brain Scans, Cambridge Cognition, Cerebrospinal Fluid (CSF) Biomarkers, Clinical Assessments, Cognitive Assessments / Screening Tools, Conversion to Dementia From Prodromal Disease, CSF Biomarkers, Deep and Frequent Phenotyping Study, Dementia Research, Dementia Research Funding, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DPUK: Dementias Platform UK, Dr Rob Buckle: Director of Science Programmes at MRC, Drug Trials Failure Rate, Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, EEG: Electroencephalography, Effectiveness of Early Detection and Treatment, Electroencephalogram (EEG) Brain Scans, Electroencephalography (EEG), Exprodo, Gait and Cognition, Gait Changes, Global Dementia Research, Global Leadership, Hypothetical Prodromes of Dementia, Imanova, Imperial College London, IXICO, Kings College London, Magnetic Resonance Imaging (MRI) Scan, Magnetoencephalography (MEG), Medical Research Council (MRC), Medical Research Council (UK), National Institute of Health Research (NIHR), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Newcastle University, Non-Invasive Biomarkers, Ocular Manifestations in Neurodegenerative Diseases, Ophthalmological Assessments, Optos, Participation in Research, Participation in Research Studies, Partnership and Collaboration, Patient and Public Participation, Positron Emission Tomography (PET), Pre-Clinical Genotype-Phenotype Predictors of Alzheimer's Disease, Prodromal Alzheimer's Disease, Professor Chris Whitty: Chief Scientific Adviser at Department of Health, Professor Simon Lovestone: Lead Researcher and Professor of Translational Neuroscience at University of Oxford, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Proteomic Analysis, Proteomics, Public Participation in Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Funding, Retina as Early Biomarker of Neurodegeneration, Retinal Biomarkers, Retinal Changes as Surrogate Biomarker for Alzheimer's Disease, Retinal Ganglion Cells (RGCs), Retinal Manifestations of Alzheimer's Disease, Sage Bionetworks, Surrogate Biomarkers of Neurodegeneration, Translational Research, TrialSpark, University College London, University of Cambridge, University of Edinburgh, University of Manchester, University of Oxford, Volunteers, Walking Pattern (Gait), Wearable Devices, Wearables (Technology), West London Mental Health Trust / Imperial College London
|
1 Comment
AAIC’s Curated Round-Up of Publications Related to the 2016 Alzheimer’s Association International Conference (Alzheimer’s Association International Conference / Alzheimer’s and Dementia)
Summary Not everyone will have been able to attend the Alzheimer’s Association International Conference in Toronto last week. The Alzheimer’s Association AAIC Press Office has been kind enough to provide a curated collection of associated publications, relating to the 2016 … Continue reading →
Posted in Charitable Bodies, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, Universal Interest
|
Tagged 2016 Alzheimer’s Association International Conference (AAIC®2016), Aboriginal and Torres Strait Islanders, Accelerating Medicines Partnership (AMP-AD), AD Genetics Consortium (ADGC), AddNeuroMed, ADNI Depression Study, Advanced Cognitive Training for Independent and Vital Elderly (ACTIVE) Study, Alzheimer's and Dementia: The Journal of the Alzheimer's Association, Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART), Alzheimer's Disease Big Data DREAM Challenge 1, Alzheimer's Disease Neuroimaging Initiative, Alzheimer’s Association, Alzheimer’s Association International Conference® (AAIC®) 2016, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Alzheimer’s Therapy Clinical Trial Results, Alzheimers and Dementia, Argentina ADNI (Arg-ADNI), Australian ADNI, Australian Imaging Biomarkers and Lifestyle Study of Aging (AIBL), Avoidable Hospital Admissions, Avoidable Hospitalizations of People With Alzheimer’s Disease: Cost to Medicare (USA), Behavioural and Psychological Symptoms of Dementia (BPSD), Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Brain Insulin and Insulin Receptors, Brain Insulin Resistance, Caregiver Burden and Dependence, Causes of Brain Insulin Resistance, China ADNI (C-ADNI), Chronic Traumatic Brain Injury, Clinical Dementia Rating–Sum of Boxes (CDR-SB), Cognitive Training, Critical Path Institute's (C-Path) Coalition Against Major Diseases (CAMD) Initiative, CSF Biomarkers, DADE Investigator Group, DADE Study, Dementia-Related Misdiagnosis, Dementia-Related Misdiagnosis (Male), Department of Defense Alzheimer's Disease Neuroimaging Initiative, Dependence in AD in England (DADE), Dependence Scale (DS), Dialogue on Reverse Engineering Assessment and Methods (DREAM) Project, Dietary Recommendations, Disease Modification, Down Syndrome Biomarker Initiative, DREAM, Drug Development for Alzheimer's Disease, Early Treatment to Reduce Costs and Mortality, EPAD, Estrogen Receptor (ESR), Estrogen Receptor Polymorphisms and Incident Dementia, European ADNI (E-ADNI), European Medical Information Framework (EMIF), Food and Drug Administration (FDA)'s Guidance for Industry Alzheimer’s Disease: Developing Drugs for the Treatment of Early Stage Disease, Formal Education and Complex Work, Framingham Heart Study, Frontotemporal Lobar Degeneration Neuroimaging Initiative, Genetic and Environmental Risk for AD Consortium (GERAD1), Global CEO Initiative for Alzheimer's Disease, Glucagon-Like Peptide-1 (GLP-1) Analogs, Imatinib Inhibition of Amyloid Precursor Protein (APP) In Humans, Imatinib Treatment and Aβ42 (In Humans), Impacts of ADNI, Incretin Mimetics, Innovative Medicine Initiative AD Research Platform, Insulin Receptor Substrate-1 (IRS-1) Signaling Pathway, Italo Monzino Foundation, Japanese ADNI (J-ADNI), Korean ADNI, Laboratory of Neuroimaging (LONI), Leuco-Methylthioninium (LMTM), Liraglutide (Victoza), LMTM Monotherapy, MBI Checklist (MBI-C), Mediterranean and DASH Diets, Mediterranean Diet, Mediterranean-DASH Intervention for Neurodegenerative Delay: MIND, Mediterranean-Dietary Approach to Systolic Hypertension (DASH) Diet, Mediterranean-Dietary Approach to Systolic Hypertension (DASH) Diet Intervention for Neurodegenerative Delay (MIND) Diet Score, Mild Behavioural Impairment (MBI), Mild Cognitive Impairment (MCI), MIND Diet, Monzino, Monzino 80-Plus Study, Neurodegeneration, Neurodegenerative Disease Research, North American Registry for Care and Research in MS, NPS Professional Interest Area (PIA), Parkinson's Progressive Markers Initiative (PPMI), Preclinical Alzheimer's Disease, Prevalence of Dementia in Aboriginal Australians, Prevalence of Dementia in China, Prevalence of Dementia in Oldest Old, Prodromal Alzheimer's Disease, Psychological Symptoms of Dementia (BPSD), Reduction of Systematic Sedation in Dementia Care, Regulation and Drug Development For Early-Stage Alzheimer's Disease, Relationship Between Age and Dementia Prevalence, Research and Development, Research and Innovation, Research Commitment, Resilience, Rush University Medical Center, Sage Bionetworks, Smell Tests For Detection of Memory Decline and Dementia, Streptozotocin (STZ), Taiwan ADNI, TauRx Therapeutics, Toronto, Transforming Research and Clinical Knowledge in Huntington's Disease (TRACK-HD), Translational Research, Translational Research Into Alzheimer's Disease in Europe, Traumatic Brain Injury, Traumatic Brain Injury (TBI), Treating Brain Insulin Resistance, Update of the Alzheimer's Disease Neuroimaging Initiative, Urban and Regional Aboriginal Australians, Urban and Rural Areas of China, Worldwide Alzheimer's Disease Neuroimaging Initiative
|
Leave a comment
Big Data Portal for Alzheimer’s Dementia Drug Discovery (NIH / Synapse AMP-AD)
Summary The National Institutes of Health (NIH) in the USA has opened a public-private partnership online resource to facilitate neurodegenerative research and drug development. The launch of the Alzheimer’s Big Data Portal provides an open-source “public knowledge portal” for the … Continue reading →
Posted in Charitable Bodies, For Doctors (mostly), For Researchers (mostly), In the News, International, Pharmacological Treatments, Quick Insights
|
Tagged Academia-Industry Partnerships, Academia-Industry Synergies, Accelerating Alzheimer's Research and Drug Development, Accelerating Medicine Partnership for Alzheimer's Disease (NIA-AMP AD) Target Discovery and Preclinical Validation Project, Accelerating Medicines Partnership (AMP), Accelerating Medicines Partnership-Alzheimer's Disease (AMP-AD), Alfred P. Sloan Foundation, Alzheimer’s Disease Biomarkers, Alzheimer’s Disease Cooperative Study, Alzheimer’s Disease Neuroimaging Initiative (ADNI), AMP-AD Program, Big Data, Big Data Portal for Alzheimer’s Dementia Drug Discovery, Big Pharma, Biomarkers, Biopharmaceutical Companies, Broad Institute of MIT and Harvard, Collaboration, Collaborative Drug Discovery Programmes, Collaborative Projects, Cross-Sector Partnerships, Dementia Research, Drug Development for Alzheimer's Disease, Drug Discovery Programmes, Drug Identification, Drug Target Validation, Drug-Development Pipeline, Drugs for Treatment of Alzheimer’s Disease, Emory University, Foundation for the NIH (FNIH), Genetic Research, Genetic Testing, Genetic Triggers, Genetics of Alzheimer's Disease, Global Open Data Initiative, Human Epigenome Atlas, Icahn School of Medicine at Mount Sinai, Institute for Systems Biology (Seattle), International Alzheimer's Disease Research Portfolio (IADRP), International Collaborations, International Organisations, International Programmes, Market Failure (Dementia Research and Drug Development), Mayo Clinic in Jacksonville, Medical Research, Multidisciplinary Research Teams, National Institutes of Health (NIH), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, NIA Genetics of Alzheimer’s Data Storage Site (NIAGADS), NIH Big Data to Knowledge (BD2K) Initiative, NIH Network for Excellence in Neuroscience Clinical Trials, Non-Profit Collaborations, Novel Targets in Neurodegeneration, Open Data, Open Data and Big Data, Open Data in Health and Social Care, Open Data Learning Capacity and Culture, Open Data: Unlocking Innovation, Open Source Solutions, Pharmaceutical Industry, Pharmacological Research, Potential of Open Data in Health and Social Care, Pre-Competitive Collaboration, Precision Medicine Initiative, Preclinical Biomarkers in Alzheimer's Disease, Public-Private Partnership (PPP), Public-Private Partnerships, Research and Development, Research and Innovation, Research Commitment, Research Consortia, Research Culture, Research Networks, Research Programmes, Roadmap Epigenomics Project, Rush University Medical Center: Chicago, Sage Bionetworks, Synapse, Synapse Access and Compliance Team, Target Discovery and Preclinical Validation, Technology Transfer, Temporal Evolution of Alzheimer’s Disease Biomarkers, Therapeutic Target(s): Identification, Translational Research, Transparency and Open Data, United States, University of California, University of Florida, US National Institute of Aging, US National Institutes of Health (NIH), USA
|
Leave a comment
UK Biobank Epidemiological Study Into Dementia Risk Factors (BBC News / Medical Research Council)
Summary A large-scale study, funded by the Medical Research Council, is to investigate the risk factors which contribute to the possibility of developing dementia. A third of a million adults in the UK, all of whom participated earlier in the … Continue reading →
Posted in Alzheimer’s Research UK, BBC News, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, National, Quick Insights, Statistics, UK, Universal Interest
|
Tagged Alzheimer's Research, Alzheimer’s Disease Biomarkers, Alzheimer’s Disease: Risk Factors, Anonymised Patient Medical Records, BBC Health News, BioBank (National Cohort), Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Brain Research, Chronic Obstructive Pulmonary Disease (COPD), Cognitive Decline, Cognitive Decline Studies, Cognitive Function in Middle Age, Cognitive Function: Tests, Decoding Inherited Disorders, Dementia Research, DNA Banks, Epidemiology, Epidemiology and Statistics, European Respiratory Society, Genetic Research, Improved Prevention Based on Underlying Predisposition, Lancet Respiratory Medicine, Large DNA Banks, Late-Life Cognitive Decline, Lifestyle Factors, Longitudinal Modelling of Cognitive Decline, Mass Memory and Reasoning Tests, Medical Research Council (MRC), Medical Research Council (UK), Medical Research Council Cognitive Function and Ageing Collaboration, Modifiable Risk Factors, Neuroepidemiology, Neuroprotective Lifestyles, Non-Invasive Biomarkers, Online Memory and Reasoning Tests, Participation in Research, Patient Involvement in Research, Public Involvement in Research, Resilience Project (Decoding Inherited Disorders), Sage Bionetworks, Tests of Cognitive Function, UK BiLEVE: UK Lung Exome Variant Evaluation Research Team, UK Biobank, Unexpected Genetic Heroes, Unhealthy Lifestyles
|
Leave a comment
